Abridge vs growththerapy
Abridge vs growththerapy, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Abridge is on 68/100 and growththerapy on 69/100.
Where each one leads
Abridge
- agent readiness: 50/100 against 38/100
growththerapy
- domain rating: 80/100 against 70/100
- headcount: 2,975 against 623
- LinkedIn following: 123,212 against 76,595
At a glance
| Measure | Abridge | growththerapy |
|---|---|---|
| What it is | Abridge provides enterprise-grade generative AI for clinical conversations, transforming patient-clinician interactions into contextually aware, clinically useful, and billable AI-generated notes for healthcare systems. | A mental health platform connecting individuals with licensed therapists and psychiatric providers, offering digital tools for matching, scheduling, and practice management. |
| Category | Healthcare | Healthcare, HealthTech, Mental Health Tech, Telemedicine |
| Sells toBusiness model | B2B | B2B2C |
| Offering | Not published | Platform |
| Founded | 2018 | 2020 |
| Headquarters | Pittsburgh, United States | New York, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Abridge | growththerapy |
|---|---|---|
| Employees | 623 | 2,975 |
| Headcount growthLast 12 months | Not published | +41.7% |
| Open roles | 47 | Not published |
| Total funding | $300M | $328M |
| Latest round | Not published | Series D |
| LinkedIn followers | 76,595 | 123,212 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Abridge | growththerapy |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 69/100 |
| Traction | 60/100 | 60/100 |
| Team | 50/100 | 70/100 |
| Search visibility | 56/100 | 38/100 |
| Quality | 78/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (38/100) |
| Domain ratingLink authority, 0-100 | 70/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Abridge | growththerapy |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | CloudFront |
| CMS | Webflow | Not detected |
| Frameworks | Tailwind CSS | Next.js, Tailwind CSS |
| Payments | Stripe | Not detected |
| Analytics | Google Tag Manager, Hotjar | Not detected |
| Support stack | Zendesk | Not detected |
Product and pricing
| Measure | Abridge | growththerapy |
|---|---|---|
| Key features | AI-Generated Clinical Notes, Contextual Reasoning Engine, EMR Integration, Revenue Cycle Optimization, Nursing Documentation, Scalability & Versatility | Not published |
What users say
| Measure | Abridge | growththerapy |
|---|---|---|
| Reddit sentimentThreads we track | 1 positive, 1 negative across 6 threads | Not published |
“So when I say I'm impressed after the first week, I mean it. Abridge has taken very complex patient visits (of the social nightmare variety, you know the kind) and turned it into a concise”r/FamilyMedicine
Abridge vs growththerapy: common questions
Which is better, Abridge or growththerapy?
On our 0-100 score growththerapy rates higher (69/100 against 68/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Abridge and growththerapy compare on the numbers?
Abridge leads on agent readiness (50/100 against 38/100). growththerapy leads on domain rating (80/100 against 70/100), headcount (2,975 against 623), LinkedIn following (123,212 against 76,595).
What do real users say about Abridge and growththerapy?
Abridge: 1 positive and 1 negative mentions across 6 Reddit threads we track, mostly in r/FamilyMedicine.
Read the full Abridge review and pricing or the growththerapy review and pricing. You can also browse other Abridge alternatives we track.